Vaccinex, Inc. Proceeds from Issuance of Private Placement
Vaccinex, Inc. (VCNX) reported Proceeds from Issuance of Private Placement of $7.30 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-04-15
- Vaccinex, Inc. proceeds from issuance of private placement for the quarter ending 2023-12-31 was $1.07M, a 71.75% decline year-over-year.
- Vaccinex, Inc. proceeds from issuance of private placement for the quarter ending 2023-09-30 was $1.23M.
- Vaccinex, Inc. proceeds from issuance of private placement for the quarter ending 2023-06-30 was $2.96M.
- Vaccinex, Inc. proceeds from issuance of private placement for the quarter ending 2023-03-31 was $2.04M, a 78.99% decline year-over-year.
- Vaccinex, Inc. proceeds from issuance of private placement for fiscal 2023 was $7.30M, a 45.87% decline from fiscal 2022.
- Vaccinex, Inc. proceeds from issuance of private placement for fiscal 2022 was $13.49M.
- Vaccinex, Inc. proceeds from issuance of private placement for fiscal 2020 was $11.47M, a 16.85% decline from fiscal 2019.
- Vaccinex, Inc. proceeds from issuance of private placement for fiscal 2019 was $13.80M.
| Period end | Proceeds from Issuance of Private Placement 1 month | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month | Proceeds from Issuance of Private Placement 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $2.30M derived: sum of 2 quarters · filed 2025-04-15 | $5.26M derived: sum of 3 quarters · filed 2025-04-15 | $7.30M 10-K · filed 2025-04-15 | $6.27M 10-K · filed 2024-04-02 | |
| 2023-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $4.19M derived: sum of 2 quarters · filed 2024-11-14 | $6.23M 10-Q · filed 2024-11-14 | $10.01M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $5.00M 10-Q · filed 2024-08-14 | $8.78M derived: sum of 3 quarters · filed 2024-08-14 | $8.78M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $2.04M 10-Q · filed 2024-05-15 | $5.82M derived: sum of 2 quarters · filed 2024-05-15 | $5.82M derived: sum of 3 quarters · filed 2024-05-15 | $5.82M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $3.78M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-04-25 | $3.78M derived: sum of 2 quarters · filed 2024-04-25 | $3.78M derived: sum of 3 quarters · filed 2024-04-25 | $13.49M 10-K/A · filed 2024-04-25 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $9.71M 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $9.71M 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $9.71M 10-Q · filed 2023-05-15 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $4.00M derived: sum of 2 quarters · filed 2022-03-31 | $4.00M derived: sum of 3 quarters · filed 2022-03-31 | $11.47M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $2.00M 10-Q · filed 2020-11-13 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $4.00M derived: sum of 2 quarters · filed 2021-11-08 | $11.47M 10-Q · filed 2021-11-08 | $11.47M derived: sum of 4 quarters · filed 2021-11-08 | |
| 2020-07-31 | $4.00M 10-Q · filed 2020-11-13 | |||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $7.47M 10-Q · filed 2021-08-16 | $7.47M derived: sum of 3 quarters · filed 2021-08-16 | $21.27M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $7.47M 10-Q · filed 2021-05-17 | $7.47M derived: sum of 2 quarters · filed 2021-05-17 | $21.27M derived: sum of 3 quarters · filed 2021-05-17 | |||
| 2020-01-31 | $7.50M 10-Q · filed 2020-11-13 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $13.80M derived: sum of 2 quarters · filed 2021-03-31 | $13.80M 10-K · filed 2021-03-31 | |||
| 2019-09-30 | $13.80M 10-K · filed 2020-03-09 | $13.80M 10-Q · filed 2020-11-13 | ||||
| 2019-07-31 | $13.80M 10-Q · filed 2020-11-13 |